Multiplex Assay Market By Type, By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
멀티플렉스 분석 시장의 2022년 시장 규모는 36억 달러로 평가되었고, 2023년부터 2032년까지 복합 연간 성장률(CAGR) 7.8%를 나타낼 전망이며 2032년에는 77억 달러에 이를 것으로 추정됩니다.
멀티플렉스 분석은 연구자가 단일 생물학적 샘플에서 여러 분석물(단백질, 핵산, 기타 분자 등)을 동시에 측정할 수 있게 해주는 실험 기술입니다. 이 방법은 한 번의 실험에서 여러 매개 변수를 효율적이고 비용 효율적으로 평가할 수 있기 때문에 유전체학, 단백질체학, 면역학, 임상 진단 등 과학 및 의학의 다양한 분야에서 유용합니다.
그러나 고액 설비 투자와 숙련 노동자 부족은 멀티플렉스 분석 시장의 성장을 제한할 것으로 예상되는 주요 요인입니다. 또한 멀티플렉스 분석 장비의 복잡하고 복잡한 특성과 함께 높은 조달 비용과 운영 비용이 멀티플렉스 분석 시장의 주요 장애물이되었습니다. 또한 분자 및 단백질 진단에서 바이오마커의 검증 증가와 높은 처리량 및 자동화 시스템의 요구 증가는 향후 세계 시장 확대에 유리한 기회를 창출할 것으로 예상됩니다. 게다가, 임상 연구 및 창약에 대한 자금 조달 증가는 멀티플렉스 시장의 성장을 더욱 촉진할 것으로 예상됩니다.
멀티플렉스 분석 시장은 유형, 제품, 용도, 최종 사용자, 지역별로 구분됩니다. 유형별로 단백질 기반 멀티플렉스 분석, 핵산 기반 멀티플렉스 분석, 세포 기반 멀티플렉스 분석으로 나뉩니다. 제품 기반에서 시장은 시약 및 소모품, 장비 및 액세서리, 소프트웨어 및 서비스로 분류됩니다. 응용 분야별로 멀티플렉스 분석 시장은 임상 진단, 연구 개발, 동반자 진단으로 분류됩니다.
목차
제1장 서론
제2장 주요 요약
제3장 시장 개요
- 시장 정의와 범위
- 주요 조사 결과
- Porter's Five Forces 분석
- 시장 역학
- 성장 촉진요인
- 만성 질환 증가
- 개별화 의약품의 채용 증가
- 다중화 제품의 기술적 진보
- 억제요인
- 기회
제4장 멀티플렉스 분석 시장 : 유형별
- 개요
- 단백질 기반 멀티플렉스 분석
- 핵산 기반 멀티플렉스 분석
- 세포 기반 멀티플렉스 분석
제5장 멀티플렉스 분석 시장 : 제품별
- 개요
- 시약?소모품
- 장치?액세서리
- 소프트웨어 및 서비스
제6장 멀티플렉스 분석 시장 : 용도별
제7장 멀티플렉스 분석 시장 : 최종 사용자별
- 개요
- 병원
- 임상검사기관
- 연구기관
- 제약 및 바이오테크놀러지 기업
제8장 멀티플렉스 분석 시장 : 지역별
- 개요
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카 및 중동 및 아프리카
제9장 경쟁 구도
- 소개
- 주요 성공 전략
- 주요 10개사의 제품 매핑
- 경쟁 대시보드
- 경쟁 히트맵
- 주요 기업의 포지셔닝(2022년)
제10장 기업 프로파일
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Randox Laboratories Limited
- Bio-Rad Laboratories, Inc.
- Abcam plc.
- Qiagen NV
- Becton, Dickinson and Company
- Seegene Inc
- MESO SCALE DIAGNOSTICS, LLC
- Diasorin SpA
BJH
According to a new report published by Allied Market Research, titled, "Multiplex Assay Market," The multiplex assay market was valued at $3.6 billion in 2022, and is estimated to reach $7.7 billion by 2032, growing at a CAGR of 7.8% from 2023 to 2032. A multiplex assay is a laboratory technique that allows researchers to simultaneously measure multiple analytes (such as proteins, nucleic acids, or other molecules) in a single biological sample. This method is valuable in various fields of science and medicine, including genomics, proteomics, immunology, and clinical diagnostics, as it enables the efficient and cost-effective assessment of multiple parameters in a single experiment.
However, high capital investments and dearth of skilled labors are the major factors that are expected to restrict the growth of the multiplex assay market. The high procurement and operational costs along with cumbersome and complex nature of multiplex assay instruments remain a key hurdle in the multiplex assay market. Moreover, increase in validation of biomarkers in molecular and protein diagnostics, along with rise in need of high-throughput and automated systems are anticipated to create lucrative opportunities for the expansion of the global market in the future. In addition, increase in funding for clinical research and drug discovery are expected to further propel the multiplex market growth.
The multiplex assay market is segmented on the basis of type, product, application, end user, and region. On the basis of type, the market is divided into protein based multiplex assay, nucleic acid-based multiplex assay, and cell-based multiplex assays. On the basis of product, the market is classified into reagents & consumables, instruments & accessories, and software & services. On the basis of application, the multiplex assay market is segregated into clinical diagnostics, research and development, and companion diagnostics.
On the basis of end user, the market is segregated into hospitals, clinical laboratories, research institutes, and pharmaceuticals & biotechnology companies. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The major players profiled in the report are Abcam plc, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., DiaSorin S.p.A. (Luminex Corporation), Illumina Inc., Meso Scale Diagnostics LLC, QIAGEN N.V., Randox Laboratories Ltd., Seegene Inc., Thermo Fisher Scientific Inc. These major players have adopted acquisition, agreement, expansion, partnership, product launch, product approval as key developmental strategy to improve the product portfolio of the multiplex assay market.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the multiplex assay market analysis from 2022 to 2032 to identify the prevailing multiplex assay market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the multiplex assay market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global multiplex assay market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Go To Market Strategy
- Market share analysis of players by products/segments
- New Product Development/ Product Matrix of Key Players
- Additional company profiles with specific to client's interest
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
- Market share analysis of players at global/region/country level
- SWOT Analysis
Key Market Segments
By End User
- Hospitals
- Clinical Laboratories
- Research Institutes
- Pharmaceutical and Biotechnology Companies
By Type
- Protein Based Multiplex Assays
- Nucleic Acid-Based Multiplex Assays
- Cell-based Multiplex Assays
By Product
- Reagents and Consumables
- Instruments and Accessories
- Software and Services
By Application
- Companion Diagnostics
- Clinical Diagnostics
- Research and Development
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players:
- Randox Laboratories Limited
- Qiagen N.V
- Seegene Inc
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Bio-Rad Laboratories, Inc.
- Abcam plc.
- Becton, Dickinson and Company
- MESO SCALE DIAGNOSTICS, LLC
- Diasorin S.p.A.
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter's five forces analysis
- 3.3.1. Low bargaining power of suppliers
- 3.3.2. Low threat of new entrants
- 3.3.3. Low threat of substitutes
- 3.3.4. Low intensity of rivalry
- 3.3.5. Low bargaining power of buyers
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Rise in prevalence of chronic disease
- 3.4.1.2. Rise in adoption of personalized medicines
- 3.4.1.3. Technological advancements in multiplexed products
- 3.4.2. Restraints
- 3.4.2.1. Lack of skilled labor/healthcare professionals
- 3.4.3. Opportunities
- 3.4.3.1. Rise in R&D activities
CHAPTER 4: MULTIPLEX ASSAY MARKET, BY TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Protein Based Multiplex Assays
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Nucleic Acid-Based Multiplex Assays
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.4. Cell-based Multiplex Assays
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
CHAPTER 5: MULTIPLEX ASSAY MARKET, BY PRODUCT
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Reagents and Consumables
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Instruments and Accessories
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.4. Software and Services
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
CHAPTER 6: MULTIPLEX ASSAY MARKET, BY APPLICATION
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Clinical Diagnostics
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Research and Development
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Companion Diagnostics
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
CHAPTER 7: MULTIPLEX ASSAY MARKET, BY END USER
- 7.1. Overview
- 7.1.1. Market size and forecast
- 7.2. Hospitals
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
- 7.3. Clinical Laboratories
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
- 7.4. Research Institutes
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country
- 7.5. Pharmaceutical and Biotechnology Companies
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by region
- 7.5.3. Market share analysis by country
CHAPTER 8: MULTIPLEX ASSAY MARKET, BY REGION
- 8.1. Overview
- 8.1.1. Market size and forecast By Region
- 8.2. North America
- 8.2.1. Key market trends, growth factors and opportunities
- 8.2.2. Market size and forecast, by Type
- 8.2.3. Market size and forecast, by Product
- 8.2.4. Market size and forecast, by Application
- 8.2.5. Market size and forecast, by End User
- 8.2.6. Market size and forecast, by country
- 8.2.6.1. U.S.
- 8.2.6.1.1. Market size and forecast, by Type
- 8.2.6.1.2. Market size and forecast, by Product
- 8.2.6.1.3. Market size and forecast, by Application
- 8.2.6.1.4. Market size and forecast, by End User
- 8.2.6.2. Canada
- 8.2.6.2.1. Market size and forecast, by Type
- 8.2.6.2.2. Market size and forecast, by Product
- 8.2.6.2.3. Market size and forecast, by Application
- 8.2.6.2.4. Market size and forecast, by End User
- 8.2.6.3. Mexico
- 8.2.6.3.1. Market size and forecast, by Type
- 8.2.6.3.2. Market size and forecast, by Product
- 8.2.6.3.3. Market size and forecast, by Application
- 8.2.6.3.4. Market size and forecast, by End User
- 8.3. Europe
- 8.3.1. Key market trends, growth factors and opportunities
- 8.3.2. Market size and forecast, by Type
- 8.3.3. Market size and forecast, by Product
- 8.3.4. Market size and forecast, by Application
- 8.3.5. Market size and forecast, by End User
- 8.3.6. Market size and forecast, by country
- 8.3.6.1. Germany
- 8.3.6.1.1. Market size and forecast, by Type
- 8.3.6.1.2. Market size and forecast, by Product
- 8.3.6.1.3. Market size and forecast, by Application
- 8.3.6.1.4. Market size and forecast, by End User
- 8.3.6.2. France
- 8.3.6.2.1. Market size and forecast, by Type
- 8.3.6.2.2. Market size and forecast, by Product
- 8.3.6.2.3. Market size and forecast, by Application
- 8.3.6.2.4. Market size and forecast, by End User
- 8.3.6.3. UK
- 8.3.6.3.1. Market size and forecast, by Type
- 8.3.6.3.2. Market size and forecast, by Product
- 8.3.6.3.3. Market size and forecast, by Application
- 8.3.6.3.4. Market size and forecast, by End User
- 8.3.6.4. Italy
- 8.3.6.4.1. Market size and forecast, by Type
- 8.3.6.4.2. Market size and forecast, by Product
- 8.3.6.4.3. Market size and forecast, by Application
- 8.3.6.4.4. Market size and forecast, by End User
- 8.3.6.5. Spain
- 8.3.6.5.1. Market size and forecast, by Type
- 8.3.6.5.2. Market size and forecast, by Product
- 8.3.6.5.3. Market size and forecast, by Application
- 8.3.6.5.4. Market size and forecast, by End User
- 8.3.6.6. Rest of Europe
- 8.3.6.6.1. Market size and forecast, by Type
- 8.3.6.6.2. Market size and forecast, by Product
- 8.3.6.6.3. Market size and forecast, by Application
- 8.3.6.6.4. Market size and forecast, by End User
- 8.4. Asia-Pacific
- 8.4.1. Key market trends, growth factors and opportunities
- 8.4.2. Market size and forecast, by Type
- 8.4.3. Market size and forecast, by Product
- 8.4.4. Market size and forecast, by Application
- 8.4.5. Market size and forecast, by End User
- 8.4.6. Market size and forecast, by country
- 8.4.6.1. Japan
- 8.4.6.1.1. Market size and forecast, by Type
- 8.4.6.1.2. Market size and forecast, by Product
- 8.4.6.1.3. Market size and forecast, by Application
- 8.4.6.1.4. Market size and forecast, by End User
- 8.4.6.2. China
- 8.4.6.2.1. Market size and forecast, by Type
- 8.4.6.2.2. Market size and forecast, by Product
- 8.4.6.2.3. Market size and forecast, by Application
- 8.4.6.2.4. Market size and forecast, by End User
- 8.4.6.3. Australia
- 8.4.6.3.1. Market size and forecast, by Type
- 8.4.6.3.2. Market size and forecast, by Product
- 8.4.6.3.3. Market size and forecast, by Application
- 8.4.6.3.4. Market size and forecast, by End User
- 8.4.6.4. India
- 8.4.6.4.1. Market size and forecast, by Type
- 8.4.6.4.2. Market size and forecast, by Product
- 8.4.6.4.3. Market size and forecast, by Application
- 8.4.6.4.4. Market size and forecast, by End User
- 8.4.6.5. South Korea
- 8.4.6.5.1. Market size and forecast, by Type
- 8.4.6.5.2. Market size and forecast, by Product
- 8.4.6.5.3. Market size and forecast, by Application
- 8.4.6.5.4. Market size and forecast, by End User
- 8.4.6.6. Rest of Asia-Pacific
- 8.4.6.6.1. Market size and forecast, by Type
- 8.4.6.6.2. Market size and forecast, by Product
- 8.4.6.6.3. Market size and forecast, by Application
- 8.4.6.6.4. Market size and forecast, by End User
- 8.5. LAMEA
- 8.5.1. Key market trends, growth factors and opportunities
- 8.5.2. Market size and forecast, by Type
- 8.5.3. Market size and forecast, by Product
- 8.5.4. Market size and forecast, by Application
- 8.5.5. Market size and forecast, by End User
- 8.5.6. Market size and forecast, by country
- 8.5.6.1. Brazil
- 8.5.6.1.1. Market size and forecast, by Type
- 8.5.6.1.2. Market size and forecast, by Product
- 8.5.6.1.3. Market size and forecast, by Application
- 8.5.6.1.4. Market size and forecast, by End User
- 8.5.6.2. Saudi Arabia
- 8.5.6.2.1. Market size and forecast, by Type
- 8.5.6.2.2. Market size and forecast, by Product
- 8.5.6.2.3. Market size and forecast, by Application
- 8.5.6.2.4. Market size and forecast, by End User
- 8.5.6.3. South Africa
- 8.5.6.3.1. Market size and forecast, by Type
- 8.5.6.3.2. Market size and forecast, by Product
- 8.5.6.3.3. Market size and forecast, by Application
- 8.5.6.3.4. Market size and forecast, by End User
- 8.5.6.4. Rest of LAMEA
- 8.5.6.4.1. Market size and forecast, by Type
- 8.5.6.4.2. Market size and forecast, by Product
- 8.5.6.4.3. Market size and forecast, by Application
- 8.5.6.4.4. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
- 9.1. Introduction
- 9.2. Top winning strategies
- 9.3. Product mapping of top 10 player
- 9.4. Competitive dashboard
- 9.5. Competitive heatmap
- 9.6. Top player positioning, 2022
CHAPTER 10: COMPANY PROFILES
- 10.1. Thermo Fisher Scientific Inc.
- 10.1.1. Company overview
- 10.1.2. Key executives
- 10.1.3. Company snapshot
- 10.1.4. Operating business segments
- 10.1.5. Product portfolio
- 10.1.6. Business performance
- 10.2. Illumina Inc.
- 10.2.1. Company overview
- 10.2.2. Key executives
- 10.2.3. Company snapshot
- 10.2.4. Operating business segments
- 10.2.5. Product portfolio
- 10.2.6. Business performance
- 10.3. Randox Laboratories Limited
- 10.3.1. Company overview
- 10.3.2. Key executives
- 10.3.3. Company snapshot
- 10.3.4. Operating business segments
- 10.3.5. Product portfolio
- 10.4. Bio-Rad Laboratories, Inc.
- 10.4.1. Company overview
- 10.4.2. Key executives
- 10.4.3. Company snapshot
- 10.4.4. Operating business segments
- 10.4.5. Product portfolio
- 10.4.6. Business performance
- 10.4.7. Key strategic moves and developments
- 10.5. Abcam plc.
- 10.5.1. Company overview
- 10.5.2. Key executives
- 10.5.3. Company snapshot
- 10.5.4. Operating business segments
- 10.5.5. Product portfolio
- 10.5.6. Business performance
- 10.6. Qiagen N.V
- 10.6.1. Company overview
- 10.6.2. Key executives
- 10.6.3. Company snapshot
- 10.6.4. Operating business segments
- 10.6.5. Product portfolio
- 10.6.6. Business performance
- 10.6.7. Key strategic moves and developments
- 10.7. Becton, Dickinson and Company
- 10.7.1. Company overview
- 10.7.2. Key executives
- 10.7.3. Company snapshot
- 10.7.4. Operating business segments
- 10.7.5. Product portfolio
- 10.7.6. Business performance
- 10.7.7. Key strategic moves and developments
- 10.8. Seegene Inc
- 10.8.1. Company overview
- 10.8.2. Key executives
- 10.8.3. Company snapshot
- 10.8.4. Operating business segments
- 10.8.5. Product portfolio
- 10.8.6. Business performance
- 10.8.7. Key strategic moves and developments
- 10.9. MESO SCALE DIAGNOSTICS, LLC
- 10.9.1. Company overview
- 10.9.2. Key executives
- 10.9.3. Company snapshot
- 10.9.4. Operating business segments
- 10.9.5. Product portfolio
- 10.10. Diasorin S.p.A.
- 10.10.1. Company overview
- 10.10.2. Key executives
- 10.10.3. Company snapshot
- 10.10.4. Operating business segments
- 10.10.5. Product portfolio
- 10.10.6. Business performance
- 10.10.7. Key strategic moves and developments
